semaglutide cardiovascular outcomes news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT semaglutide cardiovascular outcomes news today
Description
Non-obese diabetic mice aged 7 weeks were treated for 1 week with JD-5037, then euthanised
-1 Incretins have an important role in glucose homeostasis, regulation of appetite, energy expenditure and immunity
However, its clinical benefits are limited by its short half-life, which is less than 2 min because of its small size and rapid enzymatic inactivation by dipeptidyl peptidase IV
If youre using GLP-1 medication, prevent muscle loss and maintain your cardio health with this supportive program!
Join us for our show the "GLP-1 Hub Podcast" twice a week on Apple podcasts, Spotify, Amazon music and other major podcast services!
Combining intermittent fasting with tirzepatide requires careful timing and medical oversight
